leadf
logo-loader
viewNyrada
(
ASX:NYR
)

Nyrada Inc with Proactive at the ASX Small and Mid Cap Conference

Nyrada (ASX:NYR) Inc's James Bonnar speaks with Proactive at the ASX Small and Mid Cap Conference. Nyrada is a preclinical stage, drug discovery, and development company, specialising in novel small molecule drugs to treat cardiovascular and neurological diseases. It has two main programs - a cholesterol-lowering drug and a drug to treat brain injury.

Quick facts: Nyrada

Follow
ASX:NYR

Price: 0.255 AUD

Market Cap: $39.78 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Tony Locantro says gold price weakness is providing enormous buying...

Alto Capital's Tony Locantro says recent weakness in the gold price is providing what he describes as enormous buying opportunities - particularly for the likes of Mako Gold Ltd (ASX:MKG) (ASX:MKG) and Aurumin Ltd (ASX:AUN) (ASX:AUN). Locantro also discusses Eagle Mountain Mining Ltd (ASX:EM2)...

on 11/8/21

2 min read